We offer two types of service: either a detailed assessment of scientific plans for a therapeutic target, or an exploratory assessment of a particular field or topic of interest, by our group of expert advisors.
Once we receive a request for scientific advice from a client, and a plan for the work is agreed, we select a group of at least 5 neuroscience advisors, who are chosen based on their relevant multidisciplinary expertise, to provide a scientific assessment.
Clients will be informed of the identity of the selected advisors, and can request a replacement for any individual advisor selected by CNSintel prior to the start of the reviewing process. All advisors will be confirmed as being acceptable to the client prior to contacting them.
All advisors who confirm their availability to participate will sign a confidentiality agreement prior to having access to our clients’ research plans. Advisors can remain blinded as to the identity of our clients, if required. Those advisors who are not available will be replaced with the approval of the client.
Advisors carry out a peer-review style assessment of the client’s detailed scientific plan for a therapeutic target, and subsequently write a detailed report outlining comments and suggestions. Alternatively, advisors can provide a detailed scientific assessment of a particular field of interest or topic. Once a report has been prepared by the advisors, the copyright is transferred automatically to the clients.
All reports will be sent back to the client electronically within 28 days from the date an advisor signs the contract.
Protecting trade secrets and scientific knowledge is the core of our ethos. We take all the necessary steps to ensure the protection of companies’ intellectual property and scientific data. In addition, CNSintel employs IT consultants to ensure safe and secure transfer of data between clients and advisors. We use encrypted and secure servers to transfer data.